Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hawthorn Pharmaceuticals, Inc.
Madison, Mississippi, United Stateshawthornrx.com ↗
- Ownership
- Private
- Employees
- ~170
- Development stage
- Other
01
Overview
Hawthorn Pharmaceuticals was a commercial-stage specialty pharmaceutical company focused on developing and marketing prescription drugs across multiple therapeutic areas. Its lead commercial product was Granisol™ oral solution for chemotherapy/radiation-induced nausea and vomiting. The company had an active development pipeline including NDAs in various stages and at least one investigational drug ("haw AD14") targeting Alzheimer’s disease that had not yet reached approval as of the last available data. The company was acquired by Pernix Therapeutics in early 2013 and subsequently ceased independent operations[5][10].
- Therapeutic areas
- OncologyNeurology
- Modalities
- Small molecules (e.g., Granisol™ oral solution)
- Industry
- Biotech
02
Partnerships
Engaged in several in-license agreements with multinational companies; specific partners not named publicly[6].
Beyond the preview
Go deeper on Hawthorn Pharmaceuticals, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hawthorn Pharmaceuticals, Inc..